MyJournals Home  

RSS FeedsPharmaceuticals, Vol. 12, Pages 25: Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-GenŽ, for the Radiolabeling of ?-CIT with Iodine-131: Relevance for Parkinson`s Disease (Pharmaceuticals)

 
 

9 february 2019 14:00:11

 
Pharmaceuticals, Vol. 12, Pages 25: Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-GenŽ, for the Radiolabeling of ?-CIT with Iodine-131: Relevance for Parkinson`s Disease (Pharmaceuticals)
 




Parkinson’s disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to alteration of the integrity of dopaminergic transporters (DATs). In recent years, some radiopharmaceuticals have been used in the clinic to evaluate the integrity of DATs. These include tropane derivatives such as radiolabeled β-CIT and FP-CIT with iodine-123 (123I), and TRODAT-1 with metastable technetium-99 (99mTc). Radiolabeling of β-CIT with radioactive iodine is based on electrophilic radioiodination using oxidizing agents, such as Chloramine T or Iodo-Gen®. For the first time, the present work performed a comparative study of the radiolabeling of β-CIT with iodine-131 (131I), using either Chloramine T or Iodo-Gen® as oxidizing agents, in order to improve the radiolabeling process of β-CIT and to choose the most advantageous oxidizing agent to be used in nuclear medicine. Both radiolabeling methods were similar and resulted in high radiochemical yield (> 95%), with suitable 131I-β-CIT stability up to 72 h. Although Chloramine T is a strong oxidizing agent, it was as effective as Iodo-Gen® for β-CIT radiolabeling with 131I, with the advantage of briefer reaction time and solubility in aqueous medium.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
275 viewsCategory: Medicine, Pharmacology
 
Pharmaceuticals, Vol. 12, Pages 26: Curcumin and (-)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells Against Iron Toxicity and Erastin-Induced Ferroptosis (Pharmaceuticals)
Pharmaceuticals, Vol. 12, Pages 31: 2-Nitroimidazole-Furanoside Derivatives for Hypoxia Imaging--Investigation of Nucleoside Transporter Interaction, 18F-Labeling and Preclinical PET Imaging (Pharmaceuticals)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn